Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRSS1 | P07477 | 1/20 | 0.59 |
| ▸ | ACR | P10323 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 10/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | GBA1 | P04062 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12227202 | 0.94 | HSD17B10 (0.53) | PRSS1ACRLMNAKMT2ACYP1A2 | |
| SCHEMBL1101878 | 0.90 | PRSS1 (0.69) | PRSS1ACRLMNAKMT2ACYP1A2 | |
| SCHEMBL2741098 | 0.90 | PRSS1 (0.69) | PRSS1ACRLMNAKMT2ACYP1A2 | |
| SCHEMBL8929987 | 0.90 | PRSS1 (0.69) | PRSS1ACRLMNAKMT2ACYP1A2 | |
| SCHEMBL9663961 | 0.90 | PRSS1 (0.69) | PRSS1ACRLMNAKMT2ACYP1A2 | |
| SCHEMBL8930157 | 0.90 | PRSS1 (0.69) | PRSS1ACRLMNAKMT2ACYP1A2 | |
| SCHEMBL19393872 | 0.88 | ELANE (0.59) | PRSS1ACRLMNAKMT2ACYP1A2 | |
| SCHEMBL11346279 | 0.87 | PARP10 (0.64) | PRSS1ACRKMT2AMEN1TDP1 | |
| SCHEMBL14370322 | 0.87 | LMNA (0.77) | PRSS1ACRLMNAKMT2ACYP1A2 | |
| SCHEMBL11583538 | 0.87 | LMNA (0.77) | PRSS1ACRLMNAKMT2ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7871540-B2 | Polymerizable liquid crystal composition | DIC CORPORATION (JP) | 2011-01-18 | — | — | US | disclosed |
| US-20090050844-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION | DIC CORPORATION (JP) | 2009-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090050844-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION | H1-0, H1-4, H1-10 | PRSS1 2737/4885ACR 2497/4885LMNA 2712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.